We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The International Vaccine Institute, with a $34 million grant from the Samsung Foundation to support development in the field, is fully funding the Inovio-GeneOne Korean trial.